COMMUNIQUÉS West-GlobeNewswire

Italy's First Center of Robotic Excellence Established in Northern Italy at Villa Beretta Centro di Riabilitazione
09/08/2017
FREIBURG, Germany and RICHMOND, Calif., Aug. 09, 2017 (GLOBE NEWSWIRE) -- "Villa Beretta" Centro di Riabilitazione, in Costa Masnaga (LC), Italy, has been established as the first Center of Robotic Excellence in Europe [...]
Le premier Centre d'excellence robotique d'Italie a été installé au nord de l'Italie, dans le centre de Villa Beretta Centro di Riabilitazione
09/08/2017
FRIBOURG, Allemagne et RICHMOND, Californie, le 9 août 2017 (GLOBE NEWSWIRE) - « Villa Beretta » Centro di Riabilitazione (centre de rééducation) situé à Costa Masnaga (LC), Italie, a été reconnu comme le premier Centre [...]
Novo Nordisk increased reported operating profit by 8% in the first six months of 2017
09/08/2017
Sales increased by 4% measured in Danish kroner Sales increased by 4% in Danish kroner and by 3% in local currencies to DKK 57.1 billion. Sales of Tresiba ® increased by 155% to DKK 3.7 billion (149% in local currencies [...]
Mithra Pharmaceuticals: RECRUITMENT COMPLETED IN ESTELLE® POPULATION PK SUBSTUDY
09/08/2017
PRESS RELEASE ReCRUITMENT COMPLETED IN Estelle® population PK substudy Study to determine impact of demographic characteristics on the absorption, distribution and excretion of Estelle® PK study is part of the Estelle® [...]
Corbion first half 2017 results
09/08/2017
Corbion reported H1 2017 sales of € 461.9 million, an increase of 1.4% compared to H1 2016. Organic sales growth was -0.9%, mostly due to lower volumes in Bakery. EBITDA excluding one-off items in H1 2017 decreased by 1 [...]
Biocartis Group NV: Invitation to the extraordinary shareholders' meeting
09/08/2017
PRESS RELEASE: REGULATED INFORMATION Wednesday, 9 August 2017, 07:00 CEST Invitation to the extraordinary shareholders' meeting Mechelen, Belgium, 9 August 2017 - Biocartis Group NV (the 'Company' or 'Biocartis'), an [...]
Zealand Pharma A/S prices its initial public offering of American Depositary Shares on The Nasdaq Global Select Market in the United States
09/08/2017
Company announcement - No. 31/2017 Zealand Pharma A/S prices its initial public offering of American Depositary Shares on The Nasdaq Global Select Market in the United States In continuation of Zealand Pharma A/S' [...]
Zealand Pharma A/S exercises its authorization granted by its extraordinary general meeting held on July 31, 2017
09/08/2017
Company announcement - No. 30/2017 Zealand Pharma A/S exercises its authorization granted by its extraordinary general meeting held on July 31, 2017 in connection with its initial public offering of American Depositary [...]
Prothena Reports Second Quarter 2017 Financial Results and Provides R&D Update
08/08/2017
Net cash used in operating and investing activities was $36.3 million in the second quarter and $76.5 million for the first six months of 2017; quarter-end cash and restricted cash position of $475.8 million, provides [...]
Novavax Reports Second Quarter 2017 Financial Results
08/08/2017
GAITHERSBURG, Md., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced its financial results for the second quarter and six months ended June 30, 2017. Second Quarter and Subsequent [...]
Sanofi Files Suit in the U.S. to Defend its Patent Rights on Lantus®
08/08/2017
Sanofi Files Suit in the U.S. to Defend its Patent Rights on Lantus ® Paris, France - August 8, 2017 - Sanofi announced today that it filed a patent infringement suit against Merck Sharp & Dohme Corp. ("Merck") on [...]
Sanofi intente une action en justice aux Etats-Unis pour défendre les brevets de Lantus®
08/08/2017
Sanofi intente une action en justice aux Etats-Unis pour défendre les brevets de Lantus ® Paris, France - Le 8 août 2017 - Sanofi annonce aujourd'hui avoir intenté le 8 août 2017 une action en contrefaçon contre Merck [...]
Ossur Hf : Transactions in relation to share buyback program
08/08/2017
A nnouncement from Össur hf. No. 55/2017 Reykjavík, 8 August 2017 On 1 December 2016, Össur hf. initiated a new share buy-back program, see Company announcement no. 96/2016. The purpose of the share buyback program is [...]
Novo Nordisk A/S - Share repurchase programme
08/08/2017
Bagsværd, Denmark, 8 August 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]
iTeos Therapeutics SA: iTeos Therapeutics to Present at the 2017 Wedbush PacGrow Healthcare Conference
08/08/2017
iTeos Therapeutics to Present at the 2017 Wedbush PacGrow Healthcare Conference Gosselies, Belgium - August 8, 2017 - iTeos Therapeutics SA, a biotechnology company developing novel cancer immunotherapies, today [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
08/08/2017
FIT Biotech Oy Company release August 8, 2017 at 02:00 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]
uniQure Announces Second Quarter 2017 Financial Results and Recent Company Progress
08/08/2017
~ Advancing Gene Therapy Programs in Hemophilia B and Huntington's Disease ~ ~ Provides Update on Research Collaboration with Bristol-Myers Squibb ~ ~ Makes New Appointments to Company Leadership and Nominations to [...]
Verona Pharma plc Interim Results for the Six Months Ended June 30, 2017 and Clinical Development Update
08/08/2017
Completed US IPO Continues to advance lead candidate RPL554 with four clinical trials commenced LONDON, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma" or the "Company"), a [...]
Communiqué de presse relatif à la solution ophtalmique de latanoprostène bunod, 0,024%
08/08/2017
Communiqué de presse Communiqué de presse relatif à la solution ophtalmique de latanoprostène bunod, 0,024% 8 août 2017 Sophia Antipolis, France Nicox S.A. (Euronext Paris : FR0013018124, COX, éligible PEA-PME), société [...]

Pages